Condition: Obsessive-Compulsive Disorder · Sponsor: University Hospital, Grenoble
Obsessive-Compulsive Disorder (OCD) is among the most disabling psychiatric disorders as more than 40% of patients are resistant to the standard pharmacological and psychotherapy approaches and about 10% show severe disability and require institutionalization. These resistant patients may benefit from new surgical therapeutic approaches such as Deep Brain Stimulation (DBS) using high frequency stimulation of specific cerebral regions to modulate neural networks. Although promising, these results need nevertheless to be replicated and confirmed within a larger cohort of patients and considering a different main objective, instead of clinical improvement only. Indeed, despite a positive treatment response, adaptive functioning and quality of life may continue to be negatively impacted in OCD. Thus beyond symptom reduction, health-related quality of life (QoL) represents a more important objective of a treatment, as it includes both the individual's functional status and the individual's subjective perception of the impact of the illness on the patient's life. STN DBS induces significant clinical improvement, which may not be proportional to the QoL gain. Consequently, QoL appears to be a better outcome to target in the coming studies than clinical improvement alone. THe investigators thus propose a prospective study assessing the QoL changes of resistant OCD patients under STN DBS+BMT versus Best Medical Treatment (BMT) at 12 months, in order to assess the DBS induced gain in Q…
This description comes directly from the study's public registry record.
Sandra David-tchouda, MD · +33476767186 · SDavidTchouda@chugrenoble.fr
Sandrine Massicot, Master · +33476768860 · smassicot@chu-grenoble.fr
Always discuss trial participation with your own doctor first.
| CHU Henri Mondor | Créteil, France | Completed |
| University Hospital of Grenoble Michallon | Grenoble, France | Recruiting |
| Chu Nice - Hopital Pasteur | Nice, France | Recruiting |
| APHP La Pitié Salpêtrière | Paris, France | Recruiting |
| Ghu Sainte Anne | Paris, France | Recruiting |
| Universitätsklinikum Köln (AöR) | Cologne, Germany | Recruiting |
| Djurfeldt | Stockholm, Sweden | Recruiting |
| Hôpitaux Universitaires de Genève | Geneva, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02844049